Dr. Folashade Abidemi Ogunmodede, MD

Dr. Ogunmodede practices at Mercy Hospital in Coon Rapids, Minnesota, part of Sutter Health.

Dr. Ogunmodede's NPI, 1528279858, was assigned on May 25, 2007. Dr. Ogunmodede holds Minnesota license 51765.

Dr. Ogunmodede's primary practice is Mercy Hospital, at 4050 Coon Rapids Blvd, Coon Rapids, MN 55433 in Anoka County. The practice phone is (762) 236-6000.

Dr. Ogunmodede's primary practice is Mercy Hospital in Coon Rapids, Minnesota, part of Sutter Health. Dr. Ogunmodede is also affiliated with Abbott Northwestern Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Ogunmodede to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ogunmodede practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Ogunmodede's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dmand AI has Dr. Ogunmodede's licenses on file in 2 states: Minnesota and Wisconsin.

CMS data shows 423 Medicare services from Dr. Ogunmodede across 5 procedure codes in 2024, for 169 Medicare patients. Medicare paid $34,277 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 169 Medicare patients who saw Dr. Ogunmodede in 2024. The largest group is 75 to 84, with 51 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 29% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ogunmodede's median patient age at 69, with 54% women.

In 2024, Dr. Ogunmodede wrote 363 Medicare Part D claims for 158 patients. 89% of them were for generic drugs. CMS names the drug for 153 of them, across 9 drugs with 11 or more claims each, at $7,557 in total drug cost. In 2023, CMS named 89 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Ogunmodede for performance year 2024, reported as part of a group. Dr. Ogunmodede accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Dr. Ogunmodede from 2 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $95.